Combining mKate2-Kv1.3 Channel and Atto488-Hongotoxin for the Studies of Peptide Pore Blockers on Living Eukaryotic Cells

Toxins (Basel). 2022 Dec 5;14(12):858. doi: 10.3390/toxins14120858.

Abstract

The voltage-gated potassium Kv1.3 channel is an essential component of vital cellular processes which is also involved in the pathogenesis of some autoimmune, neuroinflammatory and oncological diseases. Pore blockers of the Kv1.3 channel are considered as potential drugs and are used to study Kv1 channels' structure and functions. Screening and study of the blockers require the assessment of their ability to bind the channel. Expanding the variety of methods used for this, we report on the development of the fluorescent competitive binding assay for measuring affinities of pore blockers to Kv1.3 at the membrane of mammalian cells. The assay constituents are hongotoxin 1 conjugated with Atto488, fluorescent mKate2-tagged Kv1.3 channel, which was designed to improve membrane expression of the channel in mammalian cells, confocal microscopy, and a special protocol of image processing. The assay is implemented in the "mix and measure", format and allows the screening of Kv1.3 blockers, such as peptide toxins, that bind to the extracellular vestibule of the K+-conducting pore, and analyzing their affinity.

Keywords: Kv1.3 channel; affinity; competitive binding; confocal; fluorescence; hongotoxin; patch clamp; pore blocker.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Eukaryotic Cells*
  • Kv1.3 Potassium Channel / chemistry
  • Mammals
  • Peptides / pharmacology
  • Potassium Channel Blockers / chemistry
  • Potassium Channel Blockers / pharmacology
  • Potassium Channels, Voltage-Gated*

Substances

  • Potassium Channels, Voltage-Gated
  • Peptides
  • Potassium Channel Blockers
  • Kv1.3 Potassium Channel

Grants and funding

This research was funded by the Russian Science Foundation (project N 22-14-00406).